🇮🇩 Country Profile

Indonesia

Fast-growing pharmaceutical trade with Indonesia

🇮🇩 $256M
All data from DGCIS India export records (fiscal year, April–March).
$256M
Scale
Indonesia's healthcare system receives $256M in Indian pharmaceutical products each year, affordable, quality medicine.
42%
Medicine
A diverse pharmaceutical mix: medicine ingredients, vaccines, and medicines each contributing significantly.
4.0×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Indonesia has expanded 4.0× over the decade.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Indonesia, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicine Ingredients $108M (42.3%) Vaccines $93.8M (36.7%) Medicines $41.4M (16.2%) Surgical & Hospital Supplies $9.4M (3.7%) Traditional & Herbal $2.8M (1.1%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Indonesia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Indonesia: $5.0M across 5 filings (2020-2026).